Novartis (NVS) Set to Announce Earnings on Tuesday
Novartis (NYSE:NVS) is scheduled to be issuing its Q313 quarterly earnings data on Tuesday, October 22nd. Analysts expect the company to announce earnings of $1.31 per share and revenue of $14.28 billion for the quarter.
Novartis (NYSE:NVS) traded up 0.31% on Monday, hitting $75.25. 732,286 shares of the company’s stock traded hands. Novartis has a 1-year low of $58.60 and a 1-year high of $77.10. The stock has a 50-day moving average of $75.48 and a 200-day moving average of $73.40. The company has a market cap of $184.2 billion and a P/E ratio of 19.43.
A number of analysts have recently weighed in on NVS shares. Analysts at Societe Generale raised their price target on shares of Novartis from $82.00 to $83.00 in a research note to investors on Friday, October 11th. They now have a “buy” rating on the stock. On the ratings front, analysts at JPMorgan Chase & Co. downgraded shares of Novartis from an “overweight” rating to a “neutral” rating in a research note to investors on Tuesday, October 8th. Finally, analysts at Barclays downgraded shares of Novartis from an “equal weight” rating to an “underweight” rating in a research note to investors on Monday, September 16th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company’s stock. Novartis presently has a consensus rating of “Hold” and a consensus target price of $82.00.
Novartis AG is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.